Mahfuzul Hassan
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Assistant Professor
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mahfuzul Hassan's research focuses on developing advanced nanomedicines for cancer therapy. His work involves the synthesis and application of macrocyclic histone deacetylase inhibitors, integrated into ionic nanomedicines designed to respond to near-infrared light. This approach aims to enhance therapeutic efficacy by targeting tumor cells more specifically and potentially reducing side effects.
Hassan collaborates with researchers from the University of Arkansas at Little Rock, including Nawab Ali, Monowar Hossain, Adeolu Oluremi, and Shahedur Rahman, on shared publications. His recent publication in 2026 details the design of these near-infrared-responsive nanomedicines for improved cancer treatment outcomes.
Metrics
- Publications: 1
Positions
-
Assistant Professor 2023–presentPhilander Smith College Department of Chemistry ORCID
-
Assistant Professor publications 2026Philander Smith College ORCID
Selected Publications
-
Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
Collaboration Network
Top Collaborators
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
Similar Researchers
Based on overlapping research topics